OC-13 ADVANCE study: Final results of the phase III trial with telaprevir in combination with PEG-IFN and RBV in treatment-naïve genotype 1 HCV

✍ Scribed by M. Rizzetto; P. Andreone; M. Colombo; A. Scuteri; A. Ciancio; A. Smedile; N. Adda; I.M. Jacobson

• Book ID: 119634309
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 48 KB
• Volume: 43
• Category: Article
• ISSN: 1590-8658
• DOI: 10.1016/s1590-8658(11)60014-5